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Dear Editor,
In their paper titled “Five-year Results of a Randomised
Clinical Trial of Endovenous Laser Ablation of the Great
Saphenous Vein with and without Ligation of the Sapheno-
femoral Junction”, Disselhoff et al. investigated whether
additional crossectomy is advantageous in laser treatment
of varicosity. The authors’ conclusion that crossectomy
does not improve the long-term outcome is incomprehen-
sible. Sclerotherapy was performed in 18 patients due to
insufficient lateral branches of the saphenofemoral junc-
tion. Sclerotherapy was most likely performed in those
patients who had not responded to laser therapy without
crossectomy; this therefore signified a disadvantage for the
surgical study arm.
A further point of criticism is the equation of so-called
neovascularisation and recurrence. The majority of the
neovascularisations established by duplex sonography are
clinically irrelevant and therefore insignificant phenomena
for the patient; they should not be equated with a recur-
rence. For instance, in a study performed by Hartmann
et al.1 spanning a mean follow-up period of 14 years, 78%
of the observed neorefluxes were clinically irrelevant
(<3 mm in diameter). In a study performed by Fischer2
spanning a mean follow-up period of 34 years, 63% of the
neorefluxes were clinically insignificant. The author made
no differentiation and equated neovascularisations with
recurrences, which was a disadvantage for the surgical
study arm and falsified the results of the study.
The authors’ results would probably have been entirely
different when non-responders of treatment who had
undergone sclerotherapy had also been regarded as recur-
rences, and clinically irrelevant neorefluxes had been
excluded from the evaluation.
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Response to Letter to the EditorDear Editor,
We have read the comments of your reader and would like
to answer as follows.
At 6 weeks, residual non-GSV varicose veins were
detected in 10 limbs (23%) in the EVLA with SFL group and in
eight limbs (18.6%) in the EVLA without SFL group. Acces-
sory saphenous veins were still visible in six limbs in each
group. So, there was no significant difference between the
two groups concerning additional sclerotherapy and treat-
ment of the non-GSV varicose veins did not influence the
primary outcome of the study.
As we described in the initial manuscript,1 the primary
outcome was duplex proven freedom of recurrent varicose
veins and not clinical recurrence. It is well documented
that duplex examination, performed by a vascular techni-
cian, is the golden standard in the evaluation of the venous
system and increases the homogeneity of the analysis.
The prevalence of neovascularization as a cause of recur-
rent varicose veins has been extensively debated in the liter-
ature and occurred in 20e60% of patients following surgery.
I agree that the clinical impact of neovascularization will be
more important if these vessels are in connection with
a refluxing residual GSV trunk. In this study, the rate of type 1a
recurrence 5 year after EVLAwith SFJ ligationwas zero and only
5 patients of the 14 type 1c recurrences were sufficiently
symptomatic to warrant consideration of additional treatment.
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Comment on “Intra-abdominal Hypertension and
Abdominal Compartment Syndrome after Endovascular
Repair of Ruptured Abdominal Aortic Aneurysm”Dear Editor,
We read with interest the article from Djavani Gidlund and
colleagues discussing the issue of abdominal compartment
syndrome (ACS) after endovascular aneurysm repair (EVAR)
for ruptured abdominal aortic aneurysm (RAAA).1 We
congratulate the authors for their results and are pleased to
be cited in their text. We think however, that there is the
need for some clarification.
The authors notice the difference in the rate of ACS and
the need for decompression between their study (9% resp.
6%) and ours (20% resp. 20%).2
They discuss that possible reasons might be over-
estimation of ACS or non-use of conservative therapy for
ACS by our group.
In our study, when IAH was present without organ dete-
rioration, conservative treatment was initiated in a manner
similar to the method described by Djavani Gidlund and
colleagues. Our indication for surgical decompression was
based on an IAP>20 mm Hg or abdominal perfusion pressure
(systemic mean pressure minus intra-abdominal pressure) of
<50e60 mmHg and new development of organ dysfunction
(i.e. deterioration, not complete failure). The algorithm of
abdominal pressure management is clearly stated in our
article and compareswith themethod and frequency used by
Djavani and colleagues.
In contrast to the study of Djavani and colleagues, where
the decision to performEVAR or open repair was based on the
judgment of the vascular surgeon on call, all our patients
were treated by EVAR whenever possible. Accordingly, 50%
(nZ 102) of RAAAs were treated by EVAR as compared to 23%
(nZ 29) by Djavani and colleagues. Half of our EVAR patients
were in profound shock, 33%with a systolic pressure<70mm
Hg and 17% with<50 mmHg. Of the 20% that developed ACS,
nearly 80% needed decompression laparotomy in theDOI of original article:10.1016/j.ejvs.2011.02.021.operating theatre due to IAP up to 50 mmHg. Only 6 patients
needed to be compressed secondarily in the ICU due to
refractory conservative treatment.
In conclusion, we are convinced that centers dealing
with “EVAR-whenever-possible” protocols will encounter
similar rates of ACS and that our algorithm2 will help to
prevent otherwise inevitable fatalities.
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